oxiconazole
Sources réglementaires consultées
Indications approuvées
- Traitement topique des teignes du pied, inguinale ou corporelle et du pityriasis versicolor.
Contre-indications
Absolues
- Hypersensibilité à l’un des composants de la crème.
Mises en garde cliniques
- Ne pas utiliser par voie ophtalmique ou intravaginale. — openFDA oxiconazole nitrate cream 1% set ID 04477378-cccc-4db3-9e1b-5c1d6a00bd13
- Arrêter en cas de sensibilisation ou d'irritation. Éviter le contact avec le nez, la bouche et les autres muqueuses, et ne pas appliquer sous occlusion. — openFDA oxiconazole nitrate cream 1% set ID 04477378-cccc-4db3-9e1b-5c1d6a00bd13
Effets indésirables
Communs (≥1%)
Prurit · Brûlure · Irritation
Grossesse et allaitement
N’utiliser pendant la grossesse qu’en cas de nécessité manifeste. L’oxiconazole est excrété dans le lait humain ; utiliser avec prudence pendant l’allaitement.
Bibliographie récente (PubMed)
Oxime ethers are a class of compounds containing the >C=N-O-R moiety. The presence of this moiety affects the biological activity of the compounds. In this review, the structures of oxime ethers with specific biological activity have been collected and presented, and bactericidal, fungicidal, antidepressant, anticancer and herbicidal activities, among others, are described. The review includes both those substances that are currently used as drugs (e.g., fluvoxamine, mayzent, ridogrel, oxiconazole), as well as non-drug structures for which various biological activity studies have been conducted. To the best of our knowledge, this is the first review of the biological activity of compounds containing such a moiety. The authors hope that this review will inspire scientists to take a greater interest in this group of compounds, as it constitutes an interesting research area.